Munich Reinsurance Co Stock Corp in Munich Cuts Stake in Synopsys, Inc. $SNPS

Key Points

• Munich Re cut its stake in Synopsys by 82% in Q4, selling 48,182 shares and retaining 10,560 shares valued at about $5.01 million per its latest 13F filing.
• Synopsys beat Q4 estimates with EPS of $3.77 (vs. $3.56 expected) and $2.41 billion in revenue (up 65.6% YoY), and set FY2026 EPS guidance of $14.38–$14.46.
• Multiple analysts have trimmed targets and ratings (e.g., Wells Fargo to $450, Morgan Stanley to $480, Piper Sandler to $430, HSBC downgraded to hold), leaving a MarketBeat consensus rating of Hold and an average target of $531.

Munich Reinsurance Co Stock Corp in Munich reduced its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 82.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,560 shares of the semiconductor company's stock after selling 48,182 shares during the period. Munich Reinsurance Co Stock Corp in Munich's holdings in Synopsys were worth $5,011,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company's stock valued at $8,970,415,000 after buying an additional 3,120,401 shares during the last quarter. State Street Corp boosted its position in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock valued at $4,322,273,000 after buying an additional 1,493,912 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company's stock valued at $1,393,506,000 after buying an additional 1,990,608 shares during the last quarter. Capital Research Global Investors boosted its position in shares of Synopsys by 226.6% during the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company's stock valued at $1,245,533,000 after buying an additional 1,751,432 shares during the last quarter. Finally, Van ECK Associates Corp boosted its position in shares of Synopsys by 15.3% during the third quarter. Van ECK Associates Corp now owns 2,216,908 shares of the semiconductor company's stock valued at $1,093,800,000 after buying an additional 293,784 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on SNPS. Wells Fargo & Company dropped their price objective on Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 26th. Morgan Stanley reaffirmed an "equal weight" rating and set a $480.00 price objective (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a report on Thursday, January 22nd. HSBC downgraded Synopsys from a "buy" rating to a "hold" rating and set a $455.00 target price on the stock. in a report on Friday, February 20th. Finally, Piper Sandler lowered their target price on Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $531.00.

Synopsys Stock Up 9.6%

NASDAQ SNPS opened at $500.82 on Friday. The stock's 50-day moving average price is $426.02 and its 200-day moving average price is $445.33. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The company has a market capitalization of $95.94 billion, a P/E ratio of 77.77, a price-to-earnings-growth ratio of 3.73 and a beta of 1.15.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.56 by $0.21. The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm's quarterly revenue was up 65.6% on a year-over-year basis. During the same quarter last year, the company earned $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.3 earnings per share for the current year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.